GlassScriptPhysician profile
Callie Ann Britton
NPI 1780301556
$4,042.48
in general payments reported to CMS, 2019-2025
35 companies · $1,444 in 2025
The $1,444 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $171 · 2023: $1,038 · 2024: $1,389 · 2025: $1,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,787 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,786.57 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $415.91 | 2023-2025 | Azstarys, Adlarity |
| Abbvie INC. | $390.08 | 2023-2025 | |
| Lilly USA, LLC | $387.14 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $381.49 | 2022-2025 | Rexulti |
| Pfizer INC. | $245.51 | 2023-2025 | |
| Novo Nordisk INC | $241.58 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $222.74 | 2022-2025 | Veozah |
| Verity Pharmaceuticals INC. | $206.19 | 2024-2025 | Tlando |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.70 | 2022-2025 | Xifaxan, Trulance |
| Antares Pharma, INC. | $127.31 | 2024-2025 | Xyosted |
| Exact Sciences Corporation | $117.25 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $108.34 | 2023-2025 | Rexulti, Vyepti |
| Amgen INC. | $107.76 | 2023-2025 | Repatha, Evenity, Otezla |
| Axsome Therapeutics, INC. | $101.64 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $97.33 | 2023-2025 | Shingrix, Arexvy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $85.98 | 2023-2024 | Dyanavel Xr |
| Corcept Therapeutics | $84.88 | 2024-2025 | Korlym |
| Tolmar, INC. | $70.67 | 2023-2024 | |
| Esperion Therapeutics, INC. | $66.03 | 2023-2025 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $62.03 | 2022 | |
| Ibsa Pharma INC. | $43.26 | 2023-2025 | Tirosint, Flector, Licart |
| Abbott Laboratories | $42.96 | 2025 | Freestyle Libre 3, Proclaim |
| Astrazeneca Pharmaceuticals LP | $37.02 | 2025 | Airsupra |
| Acella Pharmaceuticals, LLC | $30.90 | 2024 | NP Thyroid 60 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.12 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $22.46 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $22.14 | 2023 | Jornay Pm |
| Inspire Medical Systems, INC. | $20.65 | 2025 | Inspire |
| Neos Therapeutics, LP | $20.65 | 2023 | Adzenys Xr-Odt |
| Noven Therapeutics, LLC | $20.09 | 2023 | Xelstrym |
| Myriad Women'S Health, INC. | $18.00 | 2023 | Myrisk |
| Galderma Laboratories, L.P. | $17.74 | 2024 | |
| Cranial Technologies, INC | $17.03 | 2024 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $16.23 | 2025 | Zoryve |
| Medtronic, INC. | $14.67 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Britton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.